CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 25 enrolled
Drug / intervention
IV iron +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02107053
NCT02107053N/ACompleted
CompareCT.gov

The Effect of Pomegranate Juice on Oxidative Stress Biomarkers During Treatment With IV Iron During One Dialysis Session

Western Galilee Hospital-Nahariya·interventional·Posted Apr 8, 2014·Updated Feb 9, 2016

In Brief

A clinical study evaluating PJ and IV iron for Cardiovascular Disease (CVD). Completed, enrolled 25 participants across 1 site.

Detailed Summary

Atherosclerosis and its related cardiovascular morbidity and mortality, underlie many chronic diseases. Most atherosclerotic patients have multiple cardiovascular risk factors, which potentiate each other, causing a huge burden on health systems. In order to improve the understanding and treatment options of atherosclerosis, it is necessary to identify common basic pathways in its pathogenesis. Oxidative Stress (OS) has a major role in the pathogenesis of atherosclerosis; however, good biomarkers to determine OS are still missing.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCardiovascular Disease (CVD)
CountriesIsrael
CollaboratorsLuoxis

Timeline

N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedApr 8, 2014
Enrollment StartApr 1, 2014
Primary CompletionOct 1, 2015
Study CompletionJan 1, 2016
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 12.2 years ago

Interventions

PJdietary

IV irondrug

IV iron is routinely administered to dialysis patients worldwide to correct anemia